Proof of concept studies from Aalipour et al. and Park et al. used oncolytic vaccinia viruses to decorate cancer cells with CD19 and demonstrated targeting of CD19 CAR T to previously unrecognized tumour cells both in vitro and in vivo. This evidence concerns the gene CD19 and neoplasm.